CNBX Prescription drugs Declares New Patent Granted in Australia
REHOVOT, Israel and BETHESDA, MD., Sept. 28, 2022 /PRNewswire/ — CNBX Prescription drugs Inc. (OTCQB: CNBX), a worldwide chief within the growth of most cancers associated cannabinoid-based medication, introduced immediately that…